IMS Stock Overview
Invent Medic Sweden AB (publ), a femtech company, engages in the development of non-invasive aid for women’s health in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Invent Medic Sweden AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.82 |
| 52 Week High | SEK 1.20 |
| 52 Week Low | SEK 0.49 |
| Beta | 1.05 |
| 11 Month Change | 0% |
| 3 Month Change | 0.74% |
| 1 Year Change | -21.53% |
| 33 Year Change | -87.19% |
| 5 Year Change | -92.44% |
| Change since IPO | -77.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| IMS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 1.6% |
| 1Y | -21.5% | 22.1% | 25.5% |
Return vs Industry: IMS underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: IMS underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| IMS volatility | |
|---|---|
| IMS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: IMS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IMS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 8 | Anna Lindstrom | www.inventmedic.se |
Invent Medic Sweden AB (publ), a femtech company, engages in the development of non-invasive aid for women’s health in Sweden and internationally. It offers bladder support, a CE-marked and patented medical device against stress incontinence; and menstrual cups and accessories. The company offers its products under Efemia and FlowCup brands.
Invent Medic Sweden AB (publ) Fundamentals Summary
| IMS fundamental statistics | |
|---|---|
| Market cap | SEK 32.94m |
| Earnings (TTM) | -SEK 8.53m |
| Revenue (TTM) | SEK 6.71m |
4.9x
P/S Ratio-3.9x
P/E RatioIs IMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMS income statement (TTM) | |
|---|---|
| Revenue | SEK 6.71m |
| Cost of Revenue | SEK 1.49m |
| Gross Profit | SEK 5.22m |
| Other Expenses | SEK 13.75m |
| Earnings | -SEK 8.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 77.77% |
| Net Profit Margin | -127.21% |
| Debt/Equity Ratio | 50.5% |
How did IMS perform over the long term?
See historical performance and comparison